JP2024523822A5 - - Google Patents

Info

Publication number
JP2024523822A5
JP2024523822A5 JP2023574858A JP2023574858A JP2024523822A5 JP 2024523822 A5 JP2024523822 A5 JP 2024523822A5 JP 2023574858 A JP2023574858 A JP 2023574858A JP 2023574858 A JP2023574858 A JP 2023574858A JP 2024523822 A5 JP2024523822 A5 JP 2024523822A5
Authority
JP
Japan
Prior art keywords
indole
ethyl
fluoro
amine
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/032000 external-priority patent/WO2022256554A1/en
Publication of JP2024523822A publication Critical patent/JP2024523822A/ja
Publication of JP2024523822A5 publication Critical patent/JP2024523822A5/ja
Pending legal-status Critical Current

Links

JP2023574858A 2021-06-02 2022-06-02 フッ素化トリプタミン化合物、その類似体、及びそれを使用する方法 Pending JP2024523822A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163195943P 2021-06-02 2021-06-02
US63/195,943 2021-06-02
US202163288313P 2021-12-10 2021-12-10
US63/288,313 2021-12-10
PCT/US2022/032000 WO2022256554A1 (en) 2021-06-02 2022-06-02 Fluorinated tryptamine compounds, analogues thereof, and methods using same

Publications (2)

Publication Number Publication Date
JP2024523822A JP2024523822A (ja) 2024-07-02
JP2024523822A5 true JP2024523822A5 (cg-RX-API-DMAC7.html) 2025-06-03

Family

ID=84324579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574858A Pending JP2024523822A (ja) 2021-06-02 2022-06-02 フッ素化トリプタミン化合物、その類似体、及びそれを使用する方法

Country Status (11)

Country Link
US (1) US20240286998A1 (cg-RX-API-DMAC7.html)
EP (1) EP4347559A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024523822A (cg-RX-API-DMAC7.html)
KR (1) KR20240017363A (cg-RX-API-DMAC7.html)
AU (1) AU2022287013A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025340A2 (cg-RX-API-DMAC7.html)
CA (1) CA3220850A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018652A2 (cg-RX-API-DMAC7.html)
IL (1) IL308944A (cg-RX-API-DMAC7.html)
MX (1) MX2023014437A (cg-RX-API-DMAC7.html)
WO (1) WO2022256554A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023002557A (es) * 2020-09-01 2023-05-29 Enveric Biosciences Canada Inc Derivados de psilocibina halogenada y metodos de uso.
EP4396162A4 (en) 2021-09-03 2025-11-12 Alexander Shulgin Res Institute Inc ASYMMETRIC ALLYL TRYPTAMINES
WO2023147424A1 (en) * 2022-01-27 2023-08-03 Terran Biosciences, Inc. Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)- n-methylethan-1-amine
US12157722B1 (en) * 2023-08-03 2024-12-03 Gilgamesh Pharmaceuticals, Inc. Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
US12129234B1 (en) 2023-08-03 2024-10-29 Gilgamesh Pharmaceuticals, Inc. Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine
CN121866243A (zh) * 2023-09-07 2026-04-14 耶路撒冷希伯来大学伊森姆研究发展有限公司 致幻化合物、其制备方法及其用途
WO2025104491A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0848706B1 (en) * 1995-06-06 2003-02-05 Schering Corporation Substituted benzene-fused heterocyclics as neurokinin antagonists
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
US6100291A (en) * 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
US6800637B2 (en) * 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
JP7273731B2 (ja) * 2017-02-09 2023-05-15 カームテック、エルエルシー シロシビン誘導体を含む組成物及び方法
WO2019222552A1 (en) * 2018-05-16 2019-11-21 University Of Florida Research Foundation Methods and compositions for substituted 2,5-diketopiperazine analogs
GB201907871D0 (en) * 2019-06-03 2019-07-17 Small Pharma Ltd Therapeutic compositions
AU2021215709A1 (en) * 2020-02-04 2022-09-01 Mindset Pharma Inc. 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
LT4084791T (lt) * 2020-02-18 2025-02-25 Gilgamesh Pharmaceuticals, Inc. Specifiniai triptaminai, skirti nuotaikos sutrikimams gydyti
MX2023002557A (es) * 2020-09-01 2023-05-29 Enveric Biosciences Canada Inc Derivados de psilocibina halogenada y metodos de uso.
CA3192617A1 (en) * 2020-09-20 2022-03-24 Matthew BAGGOTT Advantageous tryptamine compositions for mental disorders or enhancement
US20240051978A1 (en) * 2020-12-07 2024-02-15 Mindset Pharma Inc. 3-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disorders

Similar Documents

Publication Publication Date Title
CN1151789C (zh) 芳基(或杂芳基)吡咯基甲醇的衍生物的应用
JP2012521428A5 (cg-RX-API-DMAC7.html)
RU2012142180A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение для лечения психотических расстройств
US20130224151A1 (en) Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain
JP2009526821A (ja) 注意欠陥多動性障害治療用の新規な医薬組成物
JP2022520061A5 (cg-RX-API-DMAC7.html)
MD3452448T2 (ro) Modulatori ai răspunsului integrat la stres
WO2006096435A1 (en) Pharmaceutical compositions for the treatment and/or prevention of depression
JP2011527683A5 (cg-RX-API-DMAC7.html)
JP2011504903A5 (cg-RX-API-DMAC7.html)
JP2013544850A5 (cg-RX-API-DMAC7.html)
JP2012521429A5 (cg-RX-API-DMAC7.html)
JP2007533686A5 (cg-RX-API-DMAC7.html)
JP2021512098A5 (cg-RX-API-DMAC7.html)
JPH08208471A (ja) 薬物反応の増強作用
JP2014502641A5 (cg-RX-API-DMAC7.html)
JP2007508360A5 (cg-RX-API-DMAC7.html)
JP2017531619A5 (cg-RX-API-DMAC7.html)
CN103402514A (zh) 用于治疗运动障碍的血清素受体激动剂组合物
JP2014505107A5 (cg-RX-API-DMAC7.html)
JP2022501434A5 (cg-RX-API-DMAC7.html)
US20250144060A1 (en) Compositions and methods for treating biofilms
JP2023549187A5 (cg-RX-API-DMAC7.html)
JP2022541938A5 (cg-RX-API-DMAC7.html)
JP2025506382A5 (cg-RX-API-DMAC7.html)